Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Am J Ophthalmol Case Rep ; 27: 101623, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35761877

ABSTRACT

Purpose: To present a novel microscope-integrated optical coherence tomography (iOCT)-guided surgical technique wherein Descemet's membrane detachment (DMD), occurring during vitrectomy, was treated intraoperatively in a patient who had previously undergone Descemet's stripping automated endothelial keratoplasty (DSAEK). Observations: The surgical technique was performed on a 75-year-old man with a history of DSAEK to intraoperatively treat DMD, which occurred during vitrectomy in the left eye. A fine needle mounted on a syringe was inserted into the supra-Descemet's space under iOCT guidance. The location of the needle was easily identified by its high reflection. The interface fluid was safely aspirated under excellent visualization of the needle tip and the interface. Successful aspiration of the interface fluid was confirmed via iOCT imaging at the end of the surgery. The graft has remained well attached to the cornea throughout the one-year postoperative follow-up. Conclusion and importance: iOCT-guided surgical interventions provide a safe and accurate approach for treating intraoperative complications in eyes with a history of DSAEK.

2.
Ophthalmol Retina ; 6(2): 153-160, 2022 02.
Article in English | MEDLINE | ID: mdl-34051418

ABSTRACT

PURPOSE: To document enlarged neovascularization elsewhere (NVE) quantitatively and morphologically using widefield swept-source (SS) OCT angiography (OCTA) with vitreoretinal interface (VRI) slab images. DESIGN: Retrospective, observational imaging study. PARTICIPANTS: The study included 46 NVE examples in 25 eyes of 21 consecutive patients who demonstrated severe proliferative diabetic retinopathy with NVE between March 2018 and June 2020 at Osaka University Hospital. METHODS: All patients underwent ophthalmologic examination, including ultra-widefield fluorescein angiography and widefield SS OCTA scans. MAIN OUTCOME MEASURES: We evaluated the area and the vascular density (VD) of NVE lesions detected on five 12 × 12-mm2 or two 15 × 9-mm2 SS OCTA panoramic VRI slab images obtained at the first and final visits. RESULTS: At baseline, the mean NVE area on OCTA was 1.85 ± 2.81 mm2, and the VD of the NVE lesions was 73.9 ± 14.6%. At the final visit, the mean NVE area on OCTA was 2.14 ± 3.14 mm2, and the mean VD of the NVE lesions was 65.3 ± 17.1%. The average NVE size change (square millimeters per month) was associated significantly with the ischemic index (P = 0.009). Growth of NVE area was classified into 2 patterns: round (61.8%) and ramified (38.2%). The round group tended to have a larger ischemic index at baseline than the ramified group (P = 0.0375). CONCLUSIONS: We quantified the size and density of NVE lesions over time. The NVE size increase was associated significantly with the severity of ischemic changes. Furthermore, the round growth pattern was correlated significantly with the ischemic index. These findings suggest that the morphologic features of NVE are associated with more severe ischemia.


Subject(s)
Diabetic Retinopathy/diagnosis , Fluorescein Angiography/methods , Retinal Neovascularization/diagnosis , Retinal Vessels/diagnostic imaging , Tomography, Optical Coherence/methods , Visual Acuity , Diabetic Retinopathy/complications , Disease Progression , Female , Fundus Oculi , Humans , Male , Middle Aged , Retinal Neovascularization/etiology , Retrospective Studies
4.
J Pediatr Endocrinol Metab ; 30(5): 525-530, 2017 May 01.
Article in English | MEDLINE | ID: mdl-28328533

ABSTRACT

BACKGROUND: Little is known regarding the relationships among circulating brain-derived neurotrophic factor (BDNF) levels and glucose or insulin in children and adolescents. The objective of this study was to investigate whether circulating BDNF levels would change during the oral glucose tolerance test (OGTT). METHODS: We performed the OGTT and measured the serial changes in BDNF levels in both plasma and serum. RESULTS: There were 22 subjects in the normal type (N) group and 20 in the borderline/diabetic type (B/D) group, defined by the results of the OGTT. Serum levels of BDNF were almost five times higher and plasma levels gradually decreased during the OGTT, whereas serum levels showed no significant change. The reduction of plasma BDNF level changes from baseline to 120 min were significantly different between the N and B/D groups (36.3% vs. 20.8%, p=0.023). CONCLUSIONS: Our results showed that plasma levels of BDNF are more sensitive to acute changes in glucose or insulin levels than serum.


Subject(s)
Biomarkers/blood , Brain-Derived Neurotrophic Factor/blood , Diabetes Mellitus, Type 2/physiopathology , Glucose Tolerance Test/adverse effects , Hyperglycemia/etiology , Adolescent , Blood Glucose/analysis , Child , Child, Preschool , Diabetes Mellitus, Type 2/complications , Female , Humans , Insulin/blood , Male
5.
Mod Rheumatol ; 23(2): 374-8, 2013 Mar.
Article in English | MEDLINE | ID: mdl-22534884

ABSTRACT

Familial Mediterranean fever (FMF) is an autosomal recessive disease affecting populations surrounding the Mediterranean area. In this case report, we report a Japanese female patient with polymyositis (PM) who presented with periodic fever. Genetic analysis revealed that she had compound heterozygous mutations in exon 2 of the MEFV gene (L110P/E148Q/R202Q). Treatment with colchicines (1.0 mg/day) successfully eliminated febrile attack and normalized the elevated levels of neutrophil CD64 expression, leading to the diagnosis of FMF. The association of FMF and PM has not previously been reported, so we discuss this rare association.


Subject(s)
Familial Mediterranean Fever/complications , Polymyositis/complications , Adult , Colchicine/therapeutic use , Cytoskeletal Proteins/genetics , DNA Mutational Analysis , Familial Mediterranean Fever/drug therapy , Familial Mediterranean Fever/genetics , Female , Heterozygote , Humans , Mutation , Polymyositis/drug therapy , Polymyositis/genetics , Pyrin , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...